Digital contact tracing technologies in epidemics (search done on 5 May 2020)
Citation: Anglemyer A, Moore THM, Parker L, et al. Digital contact tracing technologies in epidemics: a rapid review. Cochrane Database of Systematic Reviews. 2020;(8):CD013699.
What is this? Digital contact tracing is being used to prevent the transmission of COVID-19.
In this rapid Cochrane review, the authors searched for studies of the effects of digital contact tracing in infectious disease outbreaks. They did not restrict their searches by language of publication and searched for articles published between 1 January 2000 and 5 May 2020. They included 6 cohort studies and 6 modelling studies. They also identified one additional article which is awaiting assessment and 3 ongoing studies.
What was found: Overall, the effects of digital contact tracing in controlling infectious disease outbreaks are uncertain, and these technologies may have equity implications for at‐risk populations with poor internet access and poor access to digital technology.
At the time of this review, modelling studies provided low‐certainty evidence of a reduction in secondary cases if digital contact tracing is combined with other public health measures, such as self‐isolation.
At the time of this review, cohort studies provided very low-certainty evidence that digital contact tracing may produce more reliable counts of contacts and reduce time to complete contact tracing.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.